Ketcher 06101515392D 1 1.00000 0.00000 0 26 28 0 0 0 999 V2000 15.6219 -12.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.6219 -11.1799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.4704 -10.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.3687 -11.1799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.3687 -12.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.4704 -12.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.2172 -10.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.0657 -11.1799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.9142 -10.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 20.7626 -11.1799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 19.9142 -9.6327 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 21.6111 -10.6808 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 14.7235 -12.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.8750 -12.1781 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.0266 -12.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.1781 -12.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.3296 -12.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.3296 -13.6754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.3813 -13.9748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.7824 -13.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.3813 -12.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.7842 -13.0765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.3849 -12.1282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.9838 -11.3296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.9820 -11.4294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.1282 -14.2743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 2 3 1 0 0 0 3 4 2 0 0 0 4 5 1 0 0 0 5 6 2 0 0 0 1 6 1 0 0 0 4 7 1 0 0 0 7 8 2 0 0 0 8 9 1 0 0 0 9 10 1 0 0 0 9 11 2 0 0 0 10 12 1 0 0 0 1 13 1 0 0 0 13 14 1 0 0 0 14 15 1 0 0 0 15 16 1 0 0 0 16 17 1 0 0 0 17 18 2 0 0 0 18 19 1 0 0 0 19 20 1 0 0 0 20 21 1 0 0 0 17 21 1 0 0 0 20 22 2 0 0 0 22 23 1 0 0 0 23 24 2 0 0 0 24 25 1 0 0 0 21 25 2 0 0 0 18 26 1 0 0 0 M END > CHEBI:85990 > panobinostat > A hydroxamic acid obtained by formal condensation of the carboxy group of (2E)-3-[4-({[2-(2-methylindol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enoic acid with the amino group of hydroxylamine. A histone deacetylase inhibitor used (as its lactate salt) in combination with bortezomib and dexamethasone for the treatment of multiple myeloma. > 3 > LBH589; LBH 589 > (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide > panobinostat > C21H23N3O2 > 349.42620 > 349.17903 > 0 > Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1 > InChI=1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/b11-10+ > FPOHNWQLNRZRFC-ZHACJKMWSA-N > 404950-80-7 > 12257756 > 404950-80-7 > D10319 > Panobinostat > 25305451; 25377157; 25410127; 25458954; 25572329; 25608569; 25612941; 25628765; 25710456; 25802326; 25837990; 25870990; 25904215; 25939707; 25944617; 26000292; 26030093; 26051506 $$$$